Literature DB >> 2265764

Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II.

A Leys1, B Michielsen, M Leys, Y Vanrenterghem, L Missotten, B Van Damme.   

Abstract

Subretinal neovascular membranes were observed in three patients with chronic membranoproliferative glomerulonephritis type II (dense deposit disease). The first signs of glomerulonephritis occurred at respective ages of 13, 10 and 10 years; subretinal neovascular membranes were noted at respective ages of 25, 32 and 32 years. All patients had bilateral, widespread retinal pigment epithelial abnormalities. Our findings indicate that subretinal neovascularization is a complication of dense deposit disease. In one patient, the early recognition and laser treatment of an extrafoveal subretinal neovascular membrane prevented further loss of vision.

Entities:  

Mesh:

Year:  1990        PMID: 2265764     DOI: 10.1007/bf00918479

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  5 in total

1.  Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report.

Authors:  J Duvall-Young; M K MacDonald; N M McKechnie
Journal:  Br J Ophthalmol       Date:  1989-04       Impact factor: 4.638

2.  Type 2 membranoproliferative glomerulonephritis with electron-dense basement membrane alteration in the spleen.

Authors:  J Ormos; A Mágori; S Sonkodi; K Streitmann
Journal:  Arch Pathol Lab Med       Date:  1979-05       Impact factor: 5.534

3.  Extraglomerular dense deposits in dense deposit disease.

Authors:  P Thorner; R Baumal
Journal:  Arch Pathol Lab Med       Date:  1982-11       Impact factor: 5.534

4.  Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings.

Authors:  J Duvall-Young; C D Short; M F Raines; R Gokal; W Lawler
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

5.  Fundus changes in mesangiocapillary glomerulonephritis type II: vitreous fluorophotometry.

Authors:  M F Raines; J Duvall-Young; C D Short
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

  5 in total
  6 in total

Review 1.  Keypathophysiologic pathways in age-related macular disease.

Authors:  Felix Roth; Almut Bindewald; Frank G Holz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

2.  Specific eye fundus lesions in type II membranoproliferative glomerulonephritis.

Authors:  A Leys; W Proesmans; R Van Damme-Lombaerts; B Van Damme
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

3.  Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients.

Authors:  A Leys; Y Vanrenterghem; B Van Damme; B Snyers; Y Pirson; M Leys
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

4.  Retinal findings in membranoproliferative glomerulonephritis.

Authors:  Ahmad M Mansour; Luiz H Lima; J Fernando Arevalo; Miguel Hage Amaro; Virginia Lozano; Alaa Bou Ghannam; Errol W Chan
Journal:  Am J Ophthalmol Case Rep       Date:  2017-06-22

5.  Fundus changes in type III membranoproliferative glomerulonephritis: a case report.

Authors:  Masato Takei; Akira Obana; Takenori Inomata; Takao Tanaka; Tina Shiang; Yuan Bae; Tamiko Takemura; Akira Murakami
Journal:  BMC Ophthalmol       Date:  2018-03-06       Impact factor: 2.209

6.  Retinal Basal Laminar Deposits in Complement fH/fP Mouse Model of Dense Deposit Disease.

Authors:  Delu Song; Imran Mohammed; Rupak Bhuyan; Takashi Miwa; Allison Lesher Williams; Damodar Gullipalli; Sayaka Sato; Ying Song; Joshua L Dunaief; Wen-Chao Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-07-02       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.